PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ebola

Ridgeback's Ebanga (mAb114) Receives the US FDA's Approval for the Treatment of Ebola

Ridgeback's Ebanga (mAb114) Receives the US FDA's Approval for the Treatment of Ebola

December 22, 2020

Regeneron Reports the US FDA's Acceptance of Priority Review for REGN-EB3's BLA to Treat Ebola

Regeneron Reports the US FDA's Acceptance of Priority Review for REGN-EB3's BLA to Treat Ebola

April 16, 2020

Congo Approves Experimental Ebola Treatments by Gilead- Mapp- Toyama Chemical and Regeneron

Congo Approves Experimental Ebola Treatments by Gilead- Mapp- Toyama Chemical and Regeneron

August 23, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us